References
- Aström-Lilja, C., Odeberg, J. M., Ekman, E., Hägg, S. (2008). Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database. Pharmacoepidemiol Drug Saf 17:587–592.
- Brucculeri, M., Kaplan, J., Lande, L. (2005). Reversal of citalopram-induced junctional bradycardia with intravenous sodium bicarbonate. Pharmacotherapy 25:119–122.
- Cuenca, P. J., Holt, K. R., Hoefle, J. D. (2004). Seizure secondary to citalopram overdose. J Emerg Med 26:177–181.
- Flanagan, R. J. (2008). Fatal toxicity of drugs used in psychiatry. Hum Psychopharmacol 23:43–51.
- Friberg, L. E., Isbiter, G. K., Dufull, S. B. (2005). Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdose. Br J Clin Pharmacol 61:177–190.
- Isbister, G. K., Friberg, L. E., Duffull, S. B. (2006). Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose. Intensive Care Med 32:1060–1065.
- Jimmink, A., Caminada, K., Hunfeld, N. G., Touw, D. J. (2008). Clinical toxicology of citalopram after acute intoxication with the sole drug or in combination with other drugs: overview of 26 cases. Ther Drug Monit 30:365–371.
- Kanjanauthai, S., Kanluen, T., Chareonthaitawee, P. (2008). Citalopram-induced torsade de pointes: a rare life-threatening side effect. Int J Cardiol 131:e33–e34
- Megarbane, B., Aslani, A. A., Deye, N., Baud, F. J. (2008). Pharmacokinetic/pharmacodynamic modeling of cardiac toxicity in human acute overdoses: utility and limitations. Exp Opin Drug Metab Toxicol 4:1–11.
- Ostrom, M., Eriksson, A., Thorson, J., Spigset, O. (1996). Fatal overdose with citalopram. Lancet 348:339–340.
- Pacher, P., Ungvari, Z., Nanasi, P. P., Furst, S., Kecskemeti, V. (1999). Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any? Curr Med Chem 6:469–480.
- Tarabar, A. F., Hoffman, R. S., Nelson, L. (2008). Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest. J Med Toxicol 4:101–105.